Anti-Viral/Microbial Partnering and Deal-Making, San Diego, CA, USA
Event May 17
This event will assemble qualified, decision-making I.D. drug development and licensing professionals to shorten the doubling time of your drug development pipeline and product portfolio. Four sessions included: general session focuses on big deal and financial market analysis, and sessions related to small molecules, antibodies and RNAi opportunities.